Answers are grounded in this paper and cite their sources.
Screening geared to early detection in almost every case carries the risk of overdiagnosis. This may result in overtreatment, which can reduce quality of life. Three contributions provide guidance as to how to reduce dramatically the harms of screening. If utilised, these should result in the rehabilitation’ of screening and reduce prostate cancer mortality at an acceptable cost.
No takes yet. Share an insight, caveat, or question.
Laurence Klotz (2015) studied this question.
Synapse has enriched 6 related papers. Consider them for comparative context: